An Act to amend 253.13 (1); and to create 253.13 (1g) of the statutes; Relating to: newborn screening for Krabbe disease and requiring evaluation of additional lysosomal storage disorders for mandatory screening. (FE)
Date / House | Action | Journal |
---|---|---|
3/23/2021 Asm. | Introduced by Representatives Novak, Tranel, Dittrich, Kitchens, Rozar, Shankland, Skowronski, Spiros, Swearingen, Tauchen, Tusler, Vorpagel and Subeck; cosponsored by Senators Testin, Marklein, Darling, L. Taylor and Bernier | |
3/23/2021 Asm. | Read first time and referred to Committee on Health | |
4/26/2021 Asm. | Fiscal estimate received | |
4/29/2021 Asm. | Senator Roys added as a cosponsor | |
6/8/2021 Asm. | Assembly Amendment 1 offered by Representative Novak | |
7/29/2021 Asm. | Public hearing held | |
10/13/2021 Asm. | Assembly Amendment 2 offered by Representative Novak | |
1/11/2022 Asm. | Representative Subeck withdrawn as a coauthor | |
1/12/2022 Asm. | Representative Shankland withdrawn as a coauthor | |
1/12/2022 Asm. | Executive action taken | |
2/1/2022 Asm. | Report Assembly Amendment 2 adoption recommended by Committee on Health, Ayes 15, Noes 0 | |
2/1/2022 Asm. | Report passage as amended recommended by Committee on Health, Ayes 9, Noes 6 | |
2/1/2022 Asm. | Referred to committee on Rules | |
3/15/2022 Asm. | Failed to pass pursuant to Senate Joint Resolution 1 |